Doravirin intermediate as well as application and synthesis method thereof

By using ethyl 2-fluoroacetate and 4-ethoxy-1,1,1-trifluoro-3-butene-2-one as raw materials, the problems of expensive raw materials and low yield in the synthesis of existing doraviline intermediates are solved, and low-cost and high-efficiency industrial production is achieved.

CN120157613APending Publication Date: 2025-06-17SHANDONG CHENGCHUANG BLUE OCEAN PHARM TECH CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202311722583.4
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2023-12-15
Publication Date
2025-06-17

AI Technical Summary

Technical Problem

In the existing synthesis method of doraviline intermediate 2-hydroxy-3-fluoro-4-trifluoromethylpyridine, the raw materials are expensive and have low overall yields, and cannot be effectively produced on ordinary laboratories or industrial scales.

Method used

The synthesis of the doraviline intermediate 2-hydroxy-3-fluoro-4-trifluoromethylpyridine is achieved by using ethyl 2-fluoroacetate and 4-ethoxy-1,1,1-trifluoro-3-butene-2-one as raw materials.

Benefits of technology

It reduces raw material costs, shortens the process cycle, improves product yield and purity, and the process is suitable for industrial production, environmentally friendly and has few side reactions.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN120157613A_ABST
    Figure CN120157613A_ABST
Patent Text Reader

Abstract

The invention relates to a doravirin intermediate as well as application and a synthesis method thereof, and belongs to the technical field of medicinal chemistry. The synthetic method of the doravirin intermediate comprises the following steps: (1) mixing ethyl 2-fluoroacetate and 4-ethoxy-1, 1, 1-trifluoro-3-butene-2-ketone with a solvent I, and dropwise adding bis (trimethylsilyl) sodium amide to form a compound 1; (2) adding an ammonia source into the reaction liquid of the compound 1 to obtain a compound 2; (3) dissolving the compound 2 in a solvent 2, adding a catalyst, and heating for cyclization to obtain a compound 3; and (4) dissolving the compound 3 in toluene, adding thionyl chloride, and dropwise adding pyridine to obtain the 2-hydroxy-3-fluoro-4-trifluoromethylpyridine. The synthesis method is low in raw material cost, short in process period, green, environment-friendly and suitable for process amplification production.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the technical field of medicinal chemistry, and particularly to doravirine intermediates, their applications, and synthesis methods. Background Art

[0002] Like efavirenz and rilpivirine, doravirine (Pifeltro) is a non-nucleoside reverse transcriptase inhibitor (NNRTI) and needs to be used in combination with other antiretroviral drugs for the treatment of adult HIV-1 infected patients without a history of previous antiretroviral drug treatment. Doravirine is a drug with a low clearance rate, with an elimination half-life of 15 hours. It has a better effect on blood lipids and body weight than drugs of the same kind, and also has relatively good drug resistance. When used in combination with methadone, there is no need to adjust the dosage. For those who are intolerant to efavirenz and nevirapine, there is a new option in the same category.

[0003] 2-Hydroxy-3-fluoro-4-(trifluoromethyl)pyridine (CAS: 1227594-89-9) is an important intermediate for the synthesis of doravirine, and its structure is as follows: .

[0004] After retrieval, the method for synthesizing this intermediate is disclosed in the literature Org. Lett. 2015, 17, 1353-1356, and the specific synthesis route is as follows: .

[0005] It uses ethyl fluoro-bromoacetate as the starting material, reacts with 4-ethoxy-1,1,1-trifluoro-3-buten-2-one through a zinc reagent to obtain compound 5, then reacts with ammonia in methanol and is treated with phosphoric acid to obtain compound 6, namely 2-hydroxy-3-fluoro-4-(trifluoromethyl)pyridine.

[0006] The existing methods for synthesizing 2-hydroxy-3-fluoro-4-(trifluoromethyl)pyridine have the following defects: 1. All existing processes use ethyl fluoro-bromoacetate as the starting material, but this raw material is expensive and not a cheap and easily available raw material; 2. The existing processes do not have clear operating methods and require special equipment such as tubular reactors and special operations such as double dropping. When we verified the process using normal laboratory equipment, we could not obtain the product. Without special equipment, it is impossible to obtain the product in the laboratory through this process, and without special production equipment, it is also impossible to scale up production. Summary of the Invention

[0007] In view of the problems in the existing synthesis methods of 2-hydroxy-3-fluoro-4-trifluoromethylpyridine, such as expensive raw materials and low overall yield, the present invention provides a doravirine intermediate, its application and synthesis method. The present invention uses ethyl 2-fluoroacetate and 4-ethoxy-1,1,1-trifluoro-3-buten-2-one as raw materials, and performs the steps of addition, ammonolysis, cyclization and dehydroxylation respectively, and finally obtains the doravirine intermediate 2-hydroxy-3-fluoro-4-trifluoromethylpyridine, which has low raw material cost, short process cycle, is green and environmentally friendly and is suitable for process scale-up production.

[0008] In a first aspect, the present invention provides a doravirine intermediate with the structure .

[0009] In a second aspect, the present invention provides a synthesis method of a doravirine intermediate, and the synthesis route is as follows: ;

[0010] Dissolve compound 2 in solvent two, add a catalyst, and heat to cyclize to obtain compound 3.

[0011] Further, solvent two is dioxane.

[0012] Further, the catalyst is hydrochloric acid.

[0013] Further, based on compound 2, the feeding amount of dioxane is 5-8 mL / g, the feeding molar ratio of hydrochloric acid is 0.025-0.050 mol / mol, and the concentration of hydrochloric acid is 2-3 mol / mL.

[0014] In a third aspect, the present invention provides an application of a doravirine intermediate in the preparation of 2-hydroxy-3-fluoro-4-trifluoromethylpyridine. 2-Hydroxy-3-fluoro-4-trifluoromethylpyridine is an important intermediate in the synthesis of doravirine, and can thus be used to prepare doravirine.

[0015] In a fourth aspect, the present invention also provides a synthesis method of a doravirine intermediate, and the synthesis route is as follows: ;

[0016] It includes the following steps: (1) Ethyl 2-fluoroacetate and 4-ethoxy-1,1,1-trifluoro-3-buten-2-one are mixed with solvent one, and sodium bis(trimethylsilyl)amide is added dropwise to form compound 1; (2) Add an ammonia source to the reaction solution of compound 1 to obtain compound 2; (3) Dissolve compound 2 in solvent two, add a catalyst, and heat to cyclize to obtain compound 3; (4)Dissolve compound 3 in toluene, add thionyl chloride, and dropwise add pyridine to obtain 2-hydroxy-3-fluoro-4-trifluoromethylpyridine.

[0017] Furthermore, in step (1), the first solvent is an aprotic solvent, preferably at least one selected from tetrahydrofuran or toluene.

[0018] Furthermore, in step (1), the reaction temperature is -50~-25°C.

[0019] Furthermore, in step (1), based on ethyl 2-fluoroacetate, the feeding amount of 4-ethoxy-1,1,1-trifluoro-3-buten-2-one is 1.0~1.3 mol / mol, the feeding amount of sodium bis(trimethylsilyl)amide is 1.05~1.1 mol / mol, and the feeding amount of toluene is 2~5 mL / g.

[0020] Furthermore, in step (2), the reaction temperature is 35~40°C.

[0021] Furthermore, in step (2), the ammonia source is selected from ammonia or ammonia methanol solution, and the concentration of the ammonia methanol solution is preferably 20%~25%.

[0022] Furthermore, in step (2), based on ethyl 2-fluoroacetate, the feeding amount of ammonia is 3.5~4.5 mol / mol.

[0023] Furthermore, after the reaction in step (2) is completed, concentrate the reaction solution, remove the remaining ammonia and most of the methanol, then add ethyl acetate and purified water, stir and separate the layers, remove the salts generated in the reaction system, wash the organic phase with acidified water, dry and concentrate to obtain the crude product of compound 2.

[0024] Furthermore, in step (2), the acidified water is a citric acid aqueous solution.

[0025] Furthermore, add isopropyl ether to the crude product of compound 2 obtained in step (2) and perform pulping to obtain the pure product of compound 2.

[0026] Furthermore, in step (2), based on ethyl 2-fluoroacetate, the feeding amount of ethyl acetate is 5~8 mL / g, the feeding amount of acidified water is 5~8 mL / g, the acidified water is a 10% citric acid solution, and the feeding amount of isopropyl ether is 2~5 mL / g.

[0027] Furthermore, in step (3), the reaction temperature is 80~95°C.

[0028] Furthermore, in step (3), the second solvent is dioxane.

[0029] Furthermore, in step (3), the catalyst is hydrochloric acid.

[0030] Further, in step (3), based on compound 2, the feeding amount of dioxane is 5 - 8 mL / g, the molar ratio of hydrochloric acid fed is 0.025 - 0.050 mol / mol, and the concentration of hydrochloric acid is 2 - 3 mol / mL.

[0031] Further, in step (4), the reaction temperature is 55 - 65 °C.

[0032] Further, in step (4), based on compound 2, the feeding amount of toluene is 5 - 10 mL / g, the feeding amount of thionyl chloride is 5 - 8 mol / mol, and the feeding amount of pyridine is 3 - 5 mol / mol.

[0033] Further, in step (4), after the pyridine reaction ends, the reaction solution is concentrated under reduced pressure, ethyl acetate and water are added for liquid separation, the organic phase is washed with water, the aqueous phases are combined, extracted with ethyl acetate, the organic phases are combined and concentrated, and methyl tert - butyl ether is added for pulping to obtain 2 - hydroxy - 3 - fluoro - 4 - trifluoromethylpyridine.

[0034] Further, in step (4), based on compound 2, the feeding amount of methyl tert - butyl ether is 2 - 5 mL / g.

[0035] Further, step (4) also includes drying 2 - hydroxy - 3 - fluoro - 4 - trifluoromethylpyridine, and the drying method can be vacuum drying or air - blast drying.

[0036] Further, the drying method in step (4) is vacuum drying, the vacuum drying temperature is 40 - 50 °C, the vacuum degree is - 0.08 - - 0.10 MPa, and the vacuum drying time is 8 - 20 hours.

[0037] The beneficial effects of the present invention are as follows: The present invention provides a synthesis route for doravirine intermediate 2 - hydroxy - 3 - fluoro - 4 - trifluoromethylpyridine with low raw material cost, short process cycle, green environmental protection and suitable for process scale - up production. The reaction solution of compound 1 obtained by the synthesis method of the present invention can be directly subjected to the next - step reaction. The reaction solutions of compound 2 and compound 3 are simply treated and concentrated to obtain crude products which are directly subjected to the next - step reaction without special purification. Among them, compound 1 exists in the form of sodium salt in the reaction system and has no influence on the next - step transformation; in the synthesis process of compound 2, an excessive ammonia source is used, so the reaction solution of compound 2 is subjected to atmospheric distillation to remove the remaining ammonia gas and most of the methanol. Ethyl acetate and purified water are added and stirred for liquid separation to remove the salts generated in the reaction system. The organic phase is concentrated and isopropyl ether is added for pulping to obtain pure compound 2; there is no difference in the reaction of the reaction solution of compound 3 before and after purification with thionyl chloride and pyridine.

[0038] The present invention uses ethyl 2-fluoroacetate as a raw material to replace ethyl fluoro-bromoacetate in the background technology, improving the atom utilization rate, reducing the cost, and reducing halogen pollution. At the same time, the operation of the present invention is simple, with few side reactions, a short production cycle, reduced environmental protection pressure, convenient solvent recovery, greatly saving the production cost. There is little loss in the post-treatment of the intermediate, and the obtained product has a high yield and high purity, which is particularly suitable for industrial production and is meaningful for drug quality control and clinical efficacy. BRIEF DESCRIPTION OF THE DRAWINGS

[0039] In order to more clearly illustrate the technical solutions in the embodiments of the present invention or the prior art, the following will briefly introduce the drawings required for the description of the embodiments or the prior art. Obviously, for those of ordinary skill in the art, without creative efforts, other drawings can also be obtained based on these drawings.

[0040] Figure 1 It is the HPLC chromatogram of preparing Compound 3 in Example 4.

[0041] Figure 2 It is the HNMR spectrum of preparing Compound 3 in Example 4.

[0042] Figure 3 It is the MS spectrum of preparing Compound 3 in Example 4.

[0043] Figure 4 It is the HPLC chromatogram of preparing Compound 4 in Example 4.

[0044] Figure 5 It is the HNMR spectrum of preparing Compound 4 in Example 4. DETAILED DESCRIPTION OF THE EMBODIMENTS

[0045] In order to enable those skilled in the art to better understand the technical solutions in the present invention, the following will clearly and completely describe the technical solutions in the embodiments of the present invention in conjunction with the drawings in the embodiments of the present invention. Obviously, the described embodiments are only a part of the embodiments of the present invention, rather than all the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by those of ordinary skill in the art without creative efforts shall fall within the protection scope of the present invention.

[0046] Example 1 A method for synthesizing a doravirine intermediate is as follows: (1) In a 250 ml reaction flask, add 20 g of tetrahydrofuran and 10 g (94.25 mmol, 1.0 eq) of ethyl 2-fluoroacetate. Replace the air with N2, cool it with dry ice to below -35 °C, and add 20.6 g (122.5 mmol, 1.3 eq) of the raw material 4-ethoxy-1,1,1-trifluoro-3-buten-2-one. When the temperature in the reaction flask drops to -35 °C to -25 °C, measure 51.8 ml (103.6 mmol, 1.1 eq) of 2 mol / L NaHMDS tetrahydrofuran solution and add it dropwise to the reaction flask. Heat is released during the dropping process. Control the dropping rate according to the temperature of the reaction solution. The dropping time is about 1 h. After the dropping is completed, keep it warm and stir for 30 min, take a sample for HPLC detection. When the raw material ethyl 2-fluoroacetate < 1.0%, the reaction is completed.

[0047] (2) Warm up the reaction solution to 0 - 5 °C, and slowly pour in 28.8 g (424.2 mmol, 4.5 eq) of the prepared 25% ammonia methanol solution. The color of the reaction solution deepens, and the internal temperature basically remains unchanged or decreases. After warming up to 35 - 40 °C, stir and react overnight. Monitor by HPLC until compound 1 < 1.0%, then terminate the reaction. Distill off the remaining ammonia under atmospheric pressure. The ammonia distilled out can be absorbed and reused with methanol. Add 50 g of ethyl acetate and 50 g of purified water, stir for 30 min, let it stand for liquid separation. Wash the organic phase once with 50 g of 10% citric acid solution. Dry and concentrate the organic phase to obtain the crude product of compound 2. Add 30 g of isopropyl ether for pulping to obtain 15.5 g of the pure product of compound 2, and the yield is 67.1%.

[0048] (3) In a 250 ml reaction flask, add 15.5 g (63.22 mmol, 1.0 eq) of the compound 2 from the previous step, 80 g of 1,4-dioxane, and 1.6 mL (3.2 mmol, 0.05 eq) of 2 mol / L hydrochloric acid solution. Stir at 90 °C overnight. Take a sample for HPLC analysis. When the content of compound 2 is <1.0%, the reaction is terminated. Distill off the reaction solvent and water under reduced pressure to obtain the crude product of compound 3. (4) In a 250 ml reaction flask, add the crude product of compound 3 from the previous step (63.22 mmol, 1.0 eq), 77 g of toluene, and 60.2 g (505.8 mmol, 8.0 eq) of thionyl chloride. Stir at room temperature. Add 25 g (316.1 mmol, 5.0 eq) of pyridine. The reaction is exothermic. Control the temperature at 55 - 65 °C and stir for 1 h. Take a sample for HPLC analysis. When the content of compound 3 is <1.0%, the reaction is terminated. Distill off the remaining thionyl chloride under reduced pressure. Add water and ethyl acetate, let it stand and separate the layers. Wash the organic phase with water twice. Combine the aqueous phases and extract with ethyl acetate twice. Combine the organic phases, dry and concentrate to obtain the crude product of 2-hydroxy-3-fluoro-4-(trifluoromethyl)pyridine. Add 24 mL of methyl tert-butyl ether and stir to form a slurry, then filter. Dry under vacuum at 50 °C and -0.08 MPa for 16 h to obtain 7.1 g of a white solid, namely compound 4. The total yield of the four steps is 41.5%. The purity of the product detected by HPLC is 99.472%. The specific detection results are shown in Table 1.

[0049] Table 1 HPLC detection results of compound 4

[0050] Example 2 A method for synthesizing a doravirine intermediate is as follows: (1) In a 1000 ml reaction flask, add 100 g of toluene and 50 g (471.3 mmol, 1.0 eq) of ethyl 2-fluoroacetate. Replace the air with N2, cool with dry ice to below -35 °C, and add 87.1 g (518.4 mmol, 1.1 eq) of the raw material 4-ethoxy-1,1,1-trifluoro-3-buten-2-one. When the temperature in the reaction flask drops to -25 °C to -35 °C, measure 259.2 ml (518.4 mmol, 1.1 eq) of 2 mol / L NaHMDS solution in tetrahydrofuran and add it dropwise to the reaction flask. Heat is released during the dropping process. Control the dropping rate according to the temperature of the reaction solution. The dropping time is about 1 h. After the dropping is completed, keep stirring at the same temperature for 30 min. Take a sample for HPLC detection. When the content of the raw material ethyl 2-fluoroacetate is <1.0%, the reaction ends.

[0051] (2) Heat the reaction solution to 0 - 5 °C, and slowly pour in 146 g (1.89 mol, 4.0 eq) of the prepared 22% ammonia methanol solution. The color of the reaction solution deepens, and the internal temperature remains basically unchanged or decreases. After heating to 35 - 40 °C, stir the reaction overnight. Monitor by HPLC, when the content of compound 1 < 1.0%, terminate the reaction. Distill off the remaining ammonia under atmospheric pressure. The distilled ammonia can be absorbed with methanol and reused. Add 250 g of ethyl acetate and 250 g of purified water, stir for 30 min, let it stand for liquid separation. Wash the organic phase once with 250 g of acidic water (10% citric acid solution). Dry and concentrate the organic phase to obtain the crude product of compound 2. Add 150 g of isopropyl ether for pulping to obtain 83 g of the pure product of compound 2, with a yield of 71.8%.

[0052] (3) In a 1000 ml reaction flask, add 83 g (338.5 mmol, 1.0 eq) of compound 2 from the previous step, add 400 g of 1,4 - dioxane, add 6.8 mL (13.6 mmol, 0.04 eq) of 2 mol / L hydrochloric acid water, and stir at 90 °C overnight. Take a sample for HPLC, when the content of compound 2 < 1.0%, terminate the reaction. Distill off the reaction solvent and water under reduced pressure to obtain the crude product of compound 3.

[0053] (4) In a 1000 ml reaction flask, add the crude product of compound 3 from the previous step (338.5 mmol, 1.0 eq), add 400 g of toluene, add 241.6 g (2.03 mol, 6.0 eq) of thionyl chloride, and stir at room temperature. Add 107.1 g (1.35 mmol, 4.0 eq) of pyridine. The reaction is exothermic, control the temperature at 55 - 65 °C, and stir for 1 h. Take a sample for HPLC, when the content of compound 3 < 1.0%, terminate the reaction. Distill off the remaining thionyl chloride under reduced pressure. Add water and ethyl acetate, let it stand for liquid separation. Wash the organic phase twice with water. Combine the aqueous phases and extract twice with ethyl acetate. Combine the organic phases, dry and concentrate to obtain the crude product of 2 - hydroxy - 3 - fluoro - 4 - trifluoromethylpyridine. Add 120 mL of methyl tert - butyl ether for pulping and then filter. Dry under vacuum at 50 °C and - 0.08 MPa for 16 h to obtain 37.7 g of a white solid. The total yield of the four steps is 44.2%. The purity of the product detected by HPLC is 99.869%. The specific detection results are shown in Table 2.

[0054] Table 2 HPLC detection results of compound 4

[0055] Example 3 A synthetic method for a doravirine intermediate is as follows: (1) In a 5 L reaction flask, add 400 g of toluene and 200 g (1.89 mol, 1.0 eq) of ethyl 2-fluoroacetate. Replace the air with N₂, cool it with dry ice to below -35 °C, and add 316.9 g (1.89 mmol, 1.0 eq) of the raw material 4-ethoxy-1,1,1-trifluoro-3-buten-2-one. Wait until the temperature in the reaction flask drops to -25 °C to -35 °C, measure 990 ml (1.98 mol, 1.05 eq) of 2 mol / L NaHMDS tetrahydrofuran solution, and add it dropwise to the reaction flask. Heat is released during the dropping process. Control the dropping rate according to the temperature of the reaction solution. The dropping time is about 2 h. After the dropping is completed, keep stirring at a constant temperature for 30 min, take a sample for HPLC detection. When the raw material ethyl 2-fluoroacetate <1.0%, the reaction ends.

[0056] (2) Warm up the reaction solution to 0 - 5 °C, slowly pour in 468.2 g (6.6 mol, 3.5 eq) of the prepared 24% ammonia methanol solution. The color of the reaction solution deepens, and the internal temperature remains basically unchanged or decreases. After warming up to 35 - 40 °C, stir and react overnight. Monitor by HPLC until compound 1 <1.0%, then terminate the reaction. Distill off the remaining ammonia under normal pressure. The ammonia distilled out can be absorbed and reused with methanol. Add 1000 g of ethyl acetate and 1000 g of purified water, stir for 30 min, let it stand for liquid separation. Wash the organic phase once with 1000 g of acid water (10% citric acid solution). Dry and concentrate the organic phase to obtain the crude product of compound 2. Add 600 g of isopropyl ether for pulping to obtain 327 g of the pure product of compound 2, with a yield of 70.7%.

[0057] (3) In a 3 L reaction flask, add 327 g (1.33 mol, 1.0 eq) of the compound 2 from the previous step, add 1500 g of 1,4-dioxane, add 20 mL (40 mmol, 0.03 eq) of 2 mol / L hydrochloric acid water, and stir at 90 °C overnight. Take a sample for HPLC. When compound 2 <1.0%, the reaction ends. Distill off the reaction solvent and water under reduced pressure to obtain the crude product of compound 3.

[0058] (4) In a 3 L reaction flask, add the crude product of the above-step compound 3 (1.33 mol, 1.0 eq), add 1500 g of toluene, add 791 g of thionyl chloride (5.34 mol, 5.0 eq), and stir at room temperature. Add 316.5 g of pyridine (4 mol, 3.0 eq), the reaction is exothermic, control the temperature at 55 - 65 °C, and stir for 1 h. Take a sample for HPLC, when compound 3 < 1.0%, the reaction terminates. Distill off the remaining thionyl chloride under reduced pressure, add water and ethyl acetate, let it stand for liquid separation, wash the organic phase with water twice, combine the aqueous phases and extract with ethyl acetate twice, combine the organic phases, dry and concentrate to obtain the crude product of 2-hydroxy-3-fluoro-4-trifluoromethylpyridine. Add 480 mL of methyl tert-butyl ether for pulping and then filter, dry under vacuum at 50 °C and -0.08 MPa for 16 h to obtain 149 g of a white solid. The total yield of the four steps is 43.7%, and the purity of the product detected by HPLC is 99.908%. The specific detection results are shown in Table 3 below.

[0059] Table 3 HPLC Detection Results of Compound 4

[0060] Example 4 A synthetic method for a doravirine intermediate is as follows: (1) In a 20 L reaction flask, add 1290 g of toluene and 742 g of ethyl 2-fluoroacetate (6.99 mol, 1.0 eq), displace with N2, cool with dry ice to below -30 °C, add 1290 g of 4-ethoxy-1,1,1-trifluoro-3-buten-2-one (7.69 mol, 1.1 eq). Wait until the temperature in the reaction flask drops to -35 °C to -25 °C, measure 3.68 L of 2 mol / L NaHMDS tetrahydrofuran solution (7.35 mol, 1.05 eq), and add it dropwise to the reaction flask. The dropping process is exothermic, control the dropping rate according to the temperature of the reaction solution, and the dropping time is about 7 h. After the dropping is completed, keep the temperature and stir for 30 min, take a sample for HPLC detection. When the raw material ethyl 2-fluoroacetate < 1.0%, the reaction is completed.

[0061] (2) Heat the reaction solution to 0 - 5 °C, slowly pour it into 1670 g of the prepared 25% ammonia methanol solution (24.5 mol, 3.5 eq). The color of the reaction solution deepens, and the internal temperature basically remains unchanged or decreases. After heating to 35 - 40 °C, stir and react overnight. Monitor by HPLC until compound 1 < 1.0%, then the reaction terminates. Distill off the remaining ammonia under normal pressure, and the distilled ammonia can be absorbed and reused with methanol. Add 3710 g of ethyl acetate and 3710 g of purified water, stir for 30 min, let it stand for liquid separation, wash the organic phase with 3710 g of acid water (10% citric acid solution) once, dry and concentrate the organic phase to obtain the crude product of compound 2. Add 2220 g of isopropyl ether for pulping to obtain 1312 g of the pure product of compound 2, and the yield is 76.5%.

[0062] (3) In a 10 L reaction flask, add 1312 g (5.35 mol, 1.0 eq) of the compound 2 from the previous step, add 6500 g of 1,4-dioxane, add 80 mL (160 mmol, 0.03 eq) of 2 mol / L hydrochloric acid solution, and stir at 90 °C overnight. Take a sample for HPLC analysis. When the content of compound 2 is < 1.0%, the reaction is terminated. Distill off the reaction solvent and water under reduced pressure to obtain the crude product of compound 3. The HPLC detection spectrum of compound 3 is shown in detail in Figure 1 , and the results are shown in Table 4 as follows: Table 4 HPLC detection results of compound 3

[0063] The HNMR and MS spectra are shown in detail in Figure 2 and Figure 3 .

[0064] (4) In a 10 L reaction flask, add the crude product of compound 3 from the previous step (5.35 mol, 1.0 eq), add 5700 g of toluene, add 3185 g (26.9 mol, 5.0 eq) of thionyl chloride, and stir at room temperature. Add 1270 g (16.1 mol, 3.0 eq) of pyridine. The reaction is exothermic. Control the temperature at 55 - 65 °C and stir for 1 h. Take a sample for HPLC analysis. When the content of compound 3 is < 1.0%, the reaction is terminated. Distill off the remaining thionyl chloride under reduced pressure. Add water and ethyl acetate, let it stand for liquid separation. Wash the organic phase with water twice, combine the aqueous phases and extract with ethyl acetate twice. Combine the organic phases, dry and concentrate to obtain the crude product of 2-hydroxy-3-fluoro-4-(trifluoromethyl)pyridine. Add 2000 mL of methyl tert-butyl ether for pulping, then filter. Dry under vacuum at 50 °C and -0.08 MPa for 16 h to obtain 741 g of a white solid. The total yield of the four steps is 58.5%. The purity of the product detected by HPLC is 99.94%. The HPLC detection spectrum of the product is shown in detail in Figure 4 , and the results are shown in Table 5 as follows: Table 5 HPLC detection data of compound 4

[0065] The HNMR spectrum is shown in detail in Figure 5 .

[0066] Although the present invention has been described in detail by referring to the accompanying drawings and in combination with the preferred embodiments, the present invention is not limited thereto. Without departing from the spirit and essence of the present invention, those of ordinary skill in the art can make various equivalent modifications or substitutions to the embodiments of the present invention, and all such modifications or substitutions should be within the scope of the present invention. / Any person skilled in the art within the technical scope disclosed by the present invention can easily think of changes or substitutions, and all should be covered within the protection scope of the present invention.

Claims

1. Doravirine intermediate 。 2. A method for synthesizing the Doravirine intermediate as claimed in claim 1, characterized in that The synthetic route is as follows: ; Dissolve compound 2 in solvent two, add a catalyst, and heat to cyclize to obtain compound 3.

3. Use of the Doravirine intermediate as claimed in claim 1 in the preparation of 2-hydroxy-3-fluoro-4-trifluoromethylpyridine 4. A method for synthesizing a Doravirine intermediate, characterized in that The synthetic route is as follows: ; It includes the following steps: (1) Mix ethyl 2-fluoroacetate with 4-ethoxy-1,1,1-trifluoro-3-buten-2-one in solvent one, and then dropwise add sodium bis(trimethylsilyl)amide to form compound 1; (2) Add an ammonia source to the reaction solution of compound 1 to obtain compound 2; (3) Dissolve compound 2 in solvent two, add a catalyst, and heat to cyclize to obtain compound 3; (4) Dissolve compound 3 in toluene, add thionyl chloride, and dropwise add pyridine to obtain 2-hydroxy-3-fluoro-4-(trifluoromethyl)pyridine.

5. The method for synthesizing a Doravirine intermediate as claimed in claim 4, characterized in that After the reaction in step (2) is completed, concentrate the reaction solution, then add ethyl acetate and purified water, stir and separate the layers. The organic phase is washed with acidified water, dried and concentrated to obtain the crude product of compound 2.

6. The method for synthesizing a Doravirine intermediate as claimed in claim 5, characterized in that Add isopropyl ether to the crude product of compound 2 obtained in step (2) and pulp to obtain the pure product of compound 2.

7. The method for synthesizing a Doravirine intermediate as claimed in claim 6, characterized in that In step (4), after the reaction of pyridine is completed, concentrate the reaction solution under reduced pressure, add ethyl acetate and water to separate the layers. The organic phase is washed with water, the aqueous phases are combined, extracted with ethyl acetate, the organic phases are combined and concentrated, and methyl tert-butyl ether is added for pulping to obtain 2-hydroxy-3-fluoro-4-(trifluoromethyl)pyridine.